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Posttranslational Mechanisms Control the Timing
of bHLH Function and Regulate Retinal Cell Fate
spatial and temporal control of such factors is likely to
play a role in the commitment of undifferentiated retinal
progenitor cells to specific phenotypic fates. Consistent
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with this idea, gene disruption studies have shown thatUniversity of Utah
a number of these transcription factors are required for20 North 1900 East
retinal development (reviewed in Harris, 1997; LiveseySalt Lake City, Utah 84132
and Cepko, 2001). In addition, there is evidence that
the pattern of transcription factor expression changes
during retinogenesis, suggesting that specific combina-Summary
tions of transcription factors may regulate the develop-
ment of specific cell types (Perron et al., 1998). TheDuring central nervous system development, neurons
question, then, is how these factors ultimately contributeare often born in a precise temporal sequence. Basic
to the full array of retinal cells found in the mature retina.helix-loop-helix (bHLH) transcription factors are re-
In many developmental systems, basic helix-loop-quired for the development of specific subpopulations
helix (bHLH) transcription factors are intimately involvedof neurons, but how they contribute to their ordered
in the determination and differentiation of cells. In thegenesis is unclear. We show that the ability of bHLH
nervous system, proneural bHLH factors share a com-factors to regulate the development of distinct neu-
mon role of regulating neuronal differentiation (Lee,ronal subtypes in the Xenopus retina depends upon
1997). It is less clear how these genes participate inthe timing of their function. In addition, we find that
the acquisition of specific neuronal phenotypes. Duringthe timing of bHLH function can be regulated post-
Xenopus laevis retinogenesis, there are several bHLHtranslationally, so that bHLH factors with overlapping
factors that are coexpressed both temporally and spa-expression can function independently. Specifically,
tially but promote the formation of different retinal cellXNeuroD function in the retina can be inhibited by
types when overexpressed (Perron et al., 1998). For ex-glycogen synthase kinase 3 (GSK3), while Xath5
ample, Xath5, Xath3, and XNeuroD are coexpressed infunction can be inhibited by Notch. Thus, the potential
retinal progenitors. However, overexpression of Xath5of bHLH factors to regulate the development of neu-
or Xath3 during Xenopus retinal development promotesronal subtypes depends upon the context in which
the formation of early cell types, such as ganglion cellsthey function.
(Kanekar et al., 1997; Perron et al., 1999), while overex-
pression of XNeuroD promotes the differentiation of
Introduction later-born cell types (Kanekar et al., 1997).
Gene disruption studies have demonstrated that
The vertebrate central nervous system (CNS) contains bHLH factors are required for the differentiation of spe-
a vast array of distinct neuronal cell types. In many cific subpopulations of retinal neurons. For example,
regions of the nervous system, these cell types arise in mutation of the ath5 gene results in a loss of retinal
precise ratios from a pool of multipotent progenitor cells, ganglion cells in mice (Brown et al., 2001; Wang et al.,
often in a particular order. Understanding the molecular 2001) and zebrafish (Kay et al., 2001), while the differenti-
mechanisms by which this diversity is achieved is a ation of amacrine cells is delayed in NeuroD knockout
fundamental challenge of developmental neurobiology. mice (Morrow et al., 1999). Such results indicate that
The vertebrate retina is an attractive CNS structure in bHLH factors can influence neuronal differentiation but
which to elucidate the molecular basis of neuronal differ- raise the question of whether they contribute cell-type
entiation, since it contains a limited number of cell types information during retinal neurogenesis. bHLH factors
organized in a stereotypical laminar pattern (Altshuler might intrinsically specify neuronal subtypes, as has
et al., 1991). The seven classes of neurons and one been suggested for atonal and achaete-scute genes in
glia cell type found in the mature vertebrate retina are the fly peripheral nervous system and eye (Chien et al.,
generated from a common pool of multipotent progeni- 1996; Sun et al., 2000). Alternatively, the ability of bHLH
tor cells in a roughly conserved histogenic order: gan- factors to promote the differentiation of specific cell
glion cells and cones are born first, while rods and Mu¨ller types may depend, in part, upon the cellular context in
glia are born last (reviewed in Cepko et al., 1996). This which they are functioning. Since retinal progenitors
fidelity of birth order across divergent species suggests have been proposed to change over developmental time
that control of retinal cell differentiation is a highly regu- in their competence to generate subtypes of retinal neu-
lated process. rons (Cepko et al., 1996; Livesey and Cepko, 2001), this
model would suggest that the timing of bHLH factorThere are several transcription factor families that
expression or function would be an important compo-have been shown to be important intrinsic regulators of
nent in determining the phenotype of the cell that differ-neuronal differentiation (Edlund and Jessell, 1999). The
entiates in response to bHLH factor activity.
To distinguish between these possibilities, we have2 Correspondence: monica.vetter@hsc.utah.edu
focused on two closely related members of the verte-1Present address: Department of Anatomy and Cell Biology, The
brate atonal-related bHLH family: Xath5, which pro-George Washington University Medical Center, 2300 Eye Street NW,
Ross Hall, Washington, DC 20037. motes retinal ganglion cell differentiation when overex-
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Figure 1. Overexpression of XNeuroD Pro-
motes an Increase in Amacrine Cell Differenti-
ation
(A) Overexpression of XNeuroD by 16-cell
RNA injection caused a 2-fold increase in the
representation of amacrine cells and a de-
crease in bipolar cells and Mu¨ller glia, as
compared to GFP controls. The percent rep-
resentation of each cell type was calculated
as a weighted average. n  3655 cells from
17 embryos for GFP and n  2886 cells from
21 embryos for XNeuroD. Error represents
SEM; asterisk, p  0.01 by Student’s t test.
GC, ganglion cells; HC, horizontal cells; AM, amacrine cells; BP, bipolar cells; PR, photoreceptor cells; and MU, Mu¨ller glial cells.
(B) To confirm that mature amacrine cells had increased, retinal sections from injected embryos were stained with antibodies to tyrosine
hydroxylase (TH), which labels dopaminergic amacrine cells in the Xenopus retina. There was a 2-fold increase in the number of TH-positive
cells per retina from XNeuroD-injected embryos, compared to control GFP-injected embryos. n  10 embryos for GFP and n  12 embryos
for XNeuroD.
pressed, and XNeuroD, which promotes differentiation 2A). To confirm that GSK3 can inhibit XNeuroD function
and determine whether it also inhibits Xath5 function,of the later-born, amacrine cell type (Kanekar et al.,
we injected mRNA encoding GSK3, along with mRNA1997). We demonstrate that posttranslational mecha-
for either XNeuroD or Xath5, into one cell of two- tonisms independently regulate the timing of Xath5 and
four-cell stage embryos. mRNA encoding -galactosi-XNeuroD function, so that they promote the differentia-
dase was included as a tracer. To assay effects on neu-tion of early and late-born cell types, respectively. Fur-
ronal differentiation, we processed neural plate-stagedthermore, we find that other bHLH factors from multiple
embryos (stage 14–16) for whole-mount in situ hybridiza-species, including Xash1, Mash1, and scute, can also
tion, using a probe for the neural-specific N-tubulin.be regulated posttranslationally to provide control over
Ectopically expressed Xath5 or XNeuroD convertedthe timing of their function. Our results suggest that
cells within the neural plate and ventral ectoderm intoduring Xenopus retinogenesis, related bHLH factors
differentiated neurons (Kanekar et al., 1997; Lee et al.,have the ability to regulate the differentiation of overlap-
1995; Figures 2D and 2F). As expected, the ability ofping subsets of retinal neuron types rather than a unique
XNeuroD to promote ectopic neurogenesis was inhib-cell type. Thus, the actual role that an individual bHLH
ited by coexpression of GSK3 (33/36 embryos; Marcusfactor has in retinal cell fate specification in part de-
et al., 1998) (Figure 2E), while Xath5 activity was notpends upon the context in which it is active.
inhibited (0/51 embryos; Figure 2G). Xath5 retained the
ability to promote ectopic neurogenesis, even in the
presence of high doses of GSK3 mRNA, which alone
Results inhibited primary neurogenesis (22/27 embryos; Figures
2C and 2G). We conclude that GSK3 can differentially
Glycogen Synthase Kinase 3 Inhibits XNeuroD, inhibit the ability of related bHLH factors to promote
but Not Xath5, Function in the Neural Plate neuronal differentiation at neural plate stages.
Xath5 and XNeuroD commence expression at the same To provide evidence that GSK3 is directly modulat-
stage of retinal neurogenesis, as the first populations ing XNeuroD function rather than acting through inter-
of neurons are beginning to differentiate (Kanekar et al., mediate factors, we mutated the putative GSK3 phos-
1997). However, when overexpressed in retinal precur- phorylation site in XNeuroD (Figure 2A) to create a
sor cells, Xath5 promotes the differentiation of retinal GSK3-insensitive version of XNeuroD (XNeuroD[S→A]).
ganglion cells, the earliest-born retinal cell type, while Ectopically expressed XNeuroD(S→A) was capable of con-
XNeuroD promotes the differentiation of later-born cell verting cells within the neural plate and ventral ectoderm
types, such as amacrine cells (Kanekar et al., 1997; Fig- into differentiated neurons (59/62 embryos; Figure 2H),
ure 1). This raises the possibility that the function of and this was not inhibited by co-injection of GSK3
XNeuroD, but not Xath5, is inhibited at early stages of mRNA (0/48 embryos; Figure 2I). Thus, XNeuroD(S→A) is
retinal neurogenesis, thus preventing XNeuroD from both active in promoting neuronal differentiation and
promoting the differentiation of the earliest born cell insensitive to the effects of GSK3 in the neural plate.
types. To explore this possibility, we have considered
the serine-threonine kinase GSK3 as a candidate regu- Inhibition of GSK3 Signaling in the Retina Causes
lator of XNeuroD function during retinal development. XNeuroD to Promote the Earliest-Born Cell Fate
During primary neurogenesis in Xenopus, GSK3 can GSK3 is expressed in the neural plate, early eye fields,
inhibit the function of XNeuroD and prevent it from pro- and throughout the eye primordia, as well as the mature
moting neuronal differentiation (Marcus et al., 1998). retina (Marcus et al., 1998). If GSK3 is inhibiting XNeu-
GSK3 is also expressed in the developing retina (Mar- roD function at early stages of retinal neurogenesis, then
cus et al., 1998; data not shown). In addition, XNeuroD, blocking GSK3 activity should relieve this inhibition
but not Xath5, contains a consensus phosphorylation and allow XNeuroD to promote early-born cell fates. To
test this, we coexpressed XNeuroD with a dominant-site for GSK3 (SPPLSV; Marcus et al., 1998) (Figure
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were confirmed by in vivo transfection of plasmids di-
rectly into retinal progenitors at optic vesicle stages, as
previously described (Holt et al., 1990). To minimize the
pleiotropic effects on head and eye development often
seen with higher doses of dnGSK3 (Dominguez et al.,
1995; He et al., 1995; Pierce and Kimelman, 1995), we
used 10 pg of dnGSK3 mRNA, a dose that does not
cause gross phenotypic abnormalities. Retinal neurons
derived from blastomeres co-injected with dnGSK3
mRNA and XNeuroD mRNA showed a significant shift
toward a retinal ganglion cell fate, compared to GFP
controls or injections of 10 pg of dnGSK3 alone (Figure
3A; p  0.003). 63% of labeled cells adopted ganglion
cell fates at the expense of later-born cell types; this
3-fold increase was similar to that observed in retinal
progenitors in Xath5-injected embryos (Kanekar et al.,
1997). Co-injection of higher doses of dnGSK3 mRNA
(50 pg) with XNeuroD (10pg) mRNA had an even more
dramatic effect, causing 87.6%  4.3% of labeled cells
within the retina to differentiate as retinal ganglion cells
(n  687 cells from 13 embryos). Thus, endogenous
GSK3 in the developing retina appears to inhibit the
ability of ectopically expressed XNeuroD to promote
retinal ganglion cell differentiation. This effect is not
observed with all bHLH factors, since dnGSK3 did not
alter the ability of ectopically expressed Math5 to pro-
mote bipolar cell differentiation (data not shown; Brown
et al., 1998). Furthermore, retinal cells derived from blas-
tomeres co-injected with GSK3 and Xath5 mRNAs re-
tained their bias toward ganglion fates (data not shown).
To determine whether GSK3 modulates the activity
of endogenous bHLH factors during retinal develop-
ment, we injected increasing amounts dnGSK3 mRNA
and assayed for effects on retinal cell fate. Injection of
low amounts of dnGSK3 mRNA (10 pg) caused a slight
but significant increase in the representation of retinal
ganglion cells (RGCs; 23.5% 1.5%), compared to GFP
controls (18.2%  0.7%) (Figure 3B). With increasing
doses of dnGSK3 mRNA, there was an increased shift
toward the RGC fate (Figure 3B) (32.7%  3.8% RGCsFigure 2. GSK3 Inhibits XNeuroD, but Not Xath5, Activity
with 30 pg mRNA and 44.4%  10.6% RGCs with 50(A) XNeuroD contains a consensus phosphorylation site for GSK3
pg mRNA). Similarly, lipofection of dnGSK3 plasmid(SPPLSV). This site was mutated to APPLAV in XNeuroD(S→A).
(B–I) RNA was injected into one cell of two-cell stage embryos DNA into the optic vesicle resulted in significantly in-
and assayed at stage 14 by whole-mount in situ hybridization for creased RGC differentiation (28.5%  2.2%, n  264
expression of N-tubulin (dark purple). The embryos are shown in a cells from five embryos, p  0.01), compared to GFP
dorsal view with anterior at the top. The injected side is to the right
controls (20.3%  1.1%, n  1225 cells from 12 em-and is marked by -galactosidase expression (aqua). (B) A control
bryos). These results suggest that GSK3might functionembryo injected with RNA for -galactosidase showing normal
to inhibit the activity of endogenous bHLH factors, pre-N-tubulin expression in the developing primary neurons. (C) Co-
injection of RNA for GSK3 suppresses primary neurogenesis on venting them from promoting early retinal cell differenti-
the injected side. (D, F, and H) Injection of RNA for either XNeuroD, ation.
Xath5, or XNeuroD(S→A) promotes ectopic N-tubulin expression on the
injected side. (E, G, and I) Co-injection of RNA for GSK3 suppresses
Targeted Overexpression of a GSK3-Insensitiveectopic neurogenesis induced by expression of XNeuroD (E), but
Form of XNeuroD Increases Differentiated Cellsnot Xath5 (G) or XNeuroD(S→A) (I).
within the Ganglion Cell Layer
To directly demonstrate that XNeuroD can promote RGC
differentiation when GSK3 inhibition is prevented, wenegative form of GSK3 (dnGSK3; Dominguez et al.,
1995; He et al., 1995; Pierce and Kimelman, 1995) by tested the effects of overexpressing the GSK3-insensi-
tive version of XNeuroD (XNeuroD[S→A]) in the retina byinjecting mRNA at the 16-cell stage. mRNA for green
fluorescent protein (GFP) was co-injected, permitting 16-cell RNA injection. Retinal neurons derived from blas-
tomeres injected with mRNA for GFP and XNeuroD(S→A)identification of cells derived from the injected blasto-
mere. 16-cell RNA injection was used to ensure efficient showed a significant shift toward the retinal ganglion
cell fate (Figures 3C and 3G). 40% of neurons derivedcoexpression of multiple proteins and allow for control
of levels of expression. For key experiments, results from blastomeres injected with XNeuroD(S→A) mRNA
Neuron
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Figure 3. Targeted Overexpression of a GSK3-Insensitive Form of XNeuroD Increases Differentiated Cells within the Ganglion Cell Layer
(A) Overexpression of XNeuroD by 16-cell RNA injection does not promote an increase in retinal ganglion cell differentiation, compared to
control GFP injections, unless GSK3 inhibition is blocked by coexpression of dnGSK3 (10 pg) with XNeuroD. n 3655 cells from 17 embryos
for GFP, n  2797 cells from 11 embryos for dnGSK3, n  2886 cells from 21 embryos for XNeuroD, and n  338 cells from 5 embryos for
XNeuroD  dnGSK3. Error represents SEM; the asterisks represent significant difference, as compared to GFP controls, while the number
signs represent significant difference, as compared to dnGSK3 (10 pg) controls; p 0.01 by Student’s t test. GC, ganglion cells; HC, horizontal
cells; AM, amacrine cells; BP, bipolar cells; PR, photoreceptor cells; and MU, Mu¨ller glial cells.
(B) Overexpression of increasing amounts of dnGSK3 mRNA causes increased retinal ganglion cell differentiation. n  3655 cells from 17
embryos for GFP, n  2797 cells from 11 embryos for dnGSK3 (10 pg), n  270 cells from 3 embryos for dnGSK3 (30 pg), and n  616
cells from 7 embryos for dnGSK3 (50 pg). Error represents SEM; the asterisks represent significant difference, as compared to GFP controls;
p  0.01 by Student’s t test.
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adopted ganglion cell layer (GCL) fates at the expense
of later-born cell types (Figure 3C; p 0.001). This distri-
bution of labeled cell types was similar to that observed
with injection of Xath5 mRNA (Figure 3E) but differed
from those produced by either XNeuroD or GFP controls
(Figures 3D and 3F). Similarly, lipofection of XNeuroD(S→A)
plasmid into retinal progenitors at optic vesicle stages
resulted in 40%  8.0% retinal ganglion cells (n  183
cells from three embryos), which is significantly in-
creased compared to GFP controls (20.3%  1.1%, n
1225 cells from 12 embryos). These data support the
hypothesis that phosphorylation of XNeuroD at SPPLSV
normally functions to inhibit its ability to promote differ-
entiation of early-born cell types, such as ganglion cells.
In addition, it has previously been shown that both
Xath5 and XNeuroD can directly regulate the expression Figure 4. The Cells Promoted by XNeuroD(S→A) Are Differentiated
Retinal Ganglion Cellsof the POU-homeodomain transcription factor XBrn3d,
Immunohistochemistry on 14 m cryosections of retinas from em-which is expressed in differentiating and mature retinal
bryos injected with XNeuroD(S→A) mRNA at the 16-cell stage.ganglion cells (Hutcheson and Vetter, 2001). Our model
(A) Hoechst dye labels cell nuclei (blue). The GCL and lens (L) arepredicts that the ability of XNeuroD, but not Xath5, to
shown.regulate XBrn3d expression should be regulated by (B) The same section showing GFP-labeled retinal ganglion cells in
GSK3. To test this, we injected mRNA encoding Xath5, which XNeuroD(S→A) is coexpressed.
XNeuroD, or XNeuroD(S→A) either alone or together with (C) The same section showing Islet-1 positive cells within the GCL.
(D) A merged image of (A)–(C). Arrowheads indicate GFP-positive/mRNA for GSK3 at the two-cell stage and assayed for
Islet-1-positive cells in the GCL. Islet-1 is expressed in over 95% ofXBrn3d expression by in situ hybridization at open neu-
GFP-positive cells within the GCL (318/336 cells from five embryos).ral plate stages. We found that Xath5, XNeuroD, or
(E–G) Labeled cells in the GCL extend axons (arrowhead) that areXNeuroD(S→A) could each promote ectopic expression of both positive for GFP (E) and positive for neurofilament (F and G).
XBrn3d, but that only XNeuroD could be prevented from GCL, ganglion cell layer; L, lens.
doing so by coexpression of GSK3 (data not shown).
Thus, the ability of XNeuroD to regulate the expression
of a retinal ganglion cell factor depends upon whether
it is inhibited by GSK3. within the GCL was due, in part, to increased numbers
of displaced amacrine cells. However, in the Xenopus
retina, it has been shown that there are very few dis-XNeuroD(S→A) Promotes the Formation
placed amacrine cells in the GCL at the stages we exam-of Differentiated Retinal Ganglion Cells
ined (Hiscock and Straznicky, 1990; Huang and Moody,It was possible that the XNeuroD(S→A) mRNA injection
1997; Rayborn et al., 1981). In addition, only a very smallwas not promoting retinal ganglion cell differentiation
number (5%) of the GFP positive cells in the GCL werebut, rather, causing ectopic differentiation of other reti-
positive for GABA, which stains amacrine cells in thenal cell types within the GCL. We confirmed that the
Xenopus retina, including displaced amacrine cells (datalabeled cells in the GCL observed with XNeuroD(S→A)
not shown; Huang and Moody, 1998; Zhu and Straz-mRNA injections were indeed differentiated ganglion
nicky, 1993). Since the number of GFP-positive/GABA-cells by staining with Islet-1, which marks retinal gan-
positive cells in the GCL from XNeuroD(S→A)-injected em-glion cells in the Xenopus retina (Dorsky et al., 1997).
bryos (average of 4.2 cells per retina from 15 embryos)Over 95% of the GFP-positive cells within the GCL were
did not differ from GFP-injected controls (average ofpositive for Islet-1 (Figures 4A–4D; n  318/336 cells in
five cells per retina from 17 embryos; p  0.572), wefive embryos). In addition, the labeled cells extended
conclude that the observed increase in GCL cells is notGFP-positive axons that also stained positive for neuro-
due to an increase in displaced amacrine cells. Basedfilament (Figures 4E–4G) and for Pax6, which marks gan-
on three criteria: laminar position, morphology, and theglion cells (data not shown; Belecky-Adams et al., 1997;
expression of ganglion cell-specific markers, we con-Mastick et al., 1997). Since manipulation of XNeuroD
clude that the labeled retinal cells within the GCL in thenormally affects amacrine cell populations, we also
tested the possibility that the observed increase in cells XNeuroD(S→A)-injected embryos are ganglion cells.
(C) Overexpression of XNeuroD(S→A), a GSK3-insensitive form of XNeuroD, promotes retinal ganglion cell differentiation similar to that seen
with overexpression of Xath5. n  3655 cells from 17 embryos for GFP, n  2655 cells from 16 embryos for Xath5, n  2886 cells from 21
embryos for XNeuroD, and n 3141 cells from 15 embryos for XNeuroD(S→A). Error represents SEM; the asterisks represent significant difference,
as compared to GFP controls, while the number signs represent significant difference between XNeuroD and XNeuroD(S→A); p  0.01 by
Student’s t test.
(D–G) Cryostat sections through the retina of a stage 41 embryo injected at the 16-cell stage with RNA for GFP alone or in combination with
RNA for either Xath5, XNeuroD, or XNeuroD(S→A), as indicated. Nuclei were stained with Hoechst dye (blue) to visualize the retinal cell layers.
Overexpression of Xath5 (E) or XNeuroD(S→A) (G) caused an increase in the representation of GFP-labeled cells in the GCL, while overexpression
of XNeuroD (F) did not.
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at early stages of retinal development. To test this, we
mutated SPPLSI to SPPLSV (mNeuroD[I→V]; Figure 5A),
which is identical to the GSK3 consensus phosphoryla-
tion sequence found in XNeuroD. When mNeuroD(I→V)
was overexpressed by 16-cell RNA injection, only 22%
of labeled retinal neurons adopted the ganglion cell fate.
Instead, there was a significant increase in amacrine
cell differentiation (19.7%  0.7%), compared to GFP
controls (10.2% 0.5%). This is very similar to the effect
observed with overexpression of XNeuroD, which re-
sults in 21% of labeled cells adopting the amacrine cell
fate (Figure 1A). These data are confirmation of our
model that the activity of bHLH factors in the retina can
be regulated through this GSK3 consensus phosphory-
lation sequence.
bHLH Factors that Promote Early-Born Cell
Fates Promote Early Cell Cycle Exit
Proneural bHLH factors promote neuronal differentia-
tion and play a critical role in regulating the timing of
cell cycle exit (Ohnuma et al., 2002). When progenitors
are induced to differentiate early in retinogenesis, they
Figure 5. Targeted Overexpression of Mouse NeuroD Promotes go through fewer rounds of cell division, as compared
Retinal Ganglion Cell Differentiation, While a GSK3-Sensitive Form to progenitors that differentiate later. We therefore used
of Mouse NeuroD Does Not clone-size analysis to demonstrate that the timing of
(A) mNeuroD lacks a complete consensus phosphorylation site for bHLH function is regulated during retinal neurogenesis.
GSK3 (SPPLSI). This site was mutated to SPPLSV in mNeuroD(I→V). We examined clone size in embryos injected with GFP(B) Overexpression of mNeuroD by 16-cell RNA injection promotes
either alone or in combination with XNeuroD, XNeu-an increase in retinal ganglion cell differentiation, compared to con-
roD(S→A), or Xath5 mRNAs into blastomere V1.2.1, whichtrol GFP injections, suggesting that it is not inhibited by GSK3
at early stages of retinal development, while mNeuroD(I→V), which makes a fairly small contribution to the retina (Huang
contains the GSK3 consensus phosphorylation sequence, pro- and Moody, 1993). Clones derived from XNeuroD(S→A)-
motes the differentiation of later-born cell types (such as amacrine injected progenitors were 40% smaller (100.25  18.32
cells). n  3655 cells from 17 embryos for GFP, n  2583 cells from
cells per clone, n  5 embryos) than clones in either10 embryos for mNeuroD, and n  2264 cells from 7 embryos for
GFP-injected controls (164.7  14.1 cells per clone, n mNeuroD(I→V).
5 embryos, p  0.01) or XNeuroD-injected embryosError represents SEM; the asterisks represent significant difference,
as compared to GFP controls, while the number signs represent (165.0  33.6 cells per clone, n  5 embryos, p  0.48),
significant difference between mNeuroD and mNeuroD(I→V); p 0.01 suggesting that XNeuroD(S→A) is causing progenitors to
by Student’s t test. GC, ganglion cells; HC, horizontal cells; AM, exit the cell cycle earlier in retinal development than
amacrine cells; BP, bipolar cells; PR, photoreceptor cells; and MU, XNeuroD. A reduced clone size was also observed with
Mu¨ller glial cells.
overexpression of Xath5 (44.7  8.1 cells per clone, n 
5 embryos, p  0.001). Xath5 clones were significantly
smaller than XNeuroD(S→A) clones, perhaps due to theMouse NeuroD Lacks a Complete GSK3 Consensus fact that Xath5 promoted a larger increase in the repre-
Phosphorylation Site and Promotes Retinal sentation of labeled retinal ganglion cells (52%), com-
Ganglion Cell Differentiation When Overexpressed pared to XNeuroD(S→A) (40%). Thus, fewer cells in the
Unlike XNeuroD, the NeuroD protein from mouse (mNeu- Xath5 clone remained as proliferating progenitors.
roD) lacks a complete GSK3 consensus phosphoryla- To confirm that early differentiation of progenitors cor-
tion site, having the sequence SPPLSI rather than relates with early cell cycle exit when these genes are
SPPLSV (Figure 5A). If mNeuroD cannot be inhibited introduced directly into the optic vesicle, we have evalu-
by GSK3 phosphorylation, then we would predict that ated the number of labeled cells per retina following
mNeuroD should be active at early stages of retinal lipofection of the same constructs. Although these do
development and promote retinal ganglion cell differen- not represent true “clones,” since we cannot ensure that
tiation when overexpressed. Indeed, 42% of neurons they represent transfection of a single progenitor, they
derived from blastomeres injected with mNeuroD mRNA do reflect proliferative effects within the retinal neuroepi-
adopted GCL fates at the expense of later-born cell thelium itself. Consistent with our clone size analysis
types (Figure 5B; p  0.001). This distribution of labeled from the 16-cell injections, lipofection of either Xath5 or
cell types was similar to that observed with injection of XNeuroD(S→A) results in 40% fewer labeled cells per retina
XNeuroD(S→A) mRNA (Figure 3B), suggesting that mNeu- when compared to NeuroD or GFP (data not shown).
roD is not being inhibited by GSK3 at early stages of This would fit with our model that both Xath5 and XNeu-
retinal development and can thus promote early-born roD(S→A) are causing early differentiation of retinal pro-
fates. genitors. Overall, these findings support the idea that
Based upon our previous findings, we predicted that proneural genes act to promote cell cycle exit and that
introducing a GSK3 consensus phosphorylation se- the phenotype of neurons that results depends upon
the timing of their action.quence into mNeuroD would prevent it from functioning
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DNA at stage 26 should result in expression at later
stages of retinogenesis (approximately stage 31) and
was found to give a different distribution of labeled reti-
nal cell types compared to GFP transfections at stage
17/18 (compare Figures 6A and 6B). The major differ-
ence was an increase in Mu¨ller glia, the latest born retinal
cell type at the expense of ganglion cells, suggesting
that progenitors targeted at this later stage are produc-
ing later retinal cell types. Next, we lipofected Xath5
into a stage 26 eye and analyzed the effect on retinal
differentiation (Figure 6B). Xath5 did not cause an in-
crease in the representation of retinal ganglion cells.
Instead, there was an increase in the percentage of
transfected bipolar and photoreceptor cells relative to
controls (33%, p  0.13; 37%, p  0.025; Figure 6B).
There was a compensatory drop in Mu¨ller glia (100%,
p 0.001). This result is consistent with previous reports
that proneural bHLH factors promote neurogenesis at
the expense of gliogenesis (Brown et al., 1998; Cai et
al., 2000; Kanekar et al., 1997; Morrow et al., 1999).
These data demonstrate that the ability of Xath5 to pro-
mote the differentiation of specific retinal neuron types
is dependent less upon inherent retinal subtype-specific
information and more upon the cellular context in which
it is active.
The Function of Other Late-Acting bHLH Factors
Figure 6. The Timing of Xath5 Expression Influences the Retinal Can Be Modulated by GSK3
Neuron Type Decision
XNeuroD is not the only bHLH factor that appears to
(A) Lipofection of Xath5 at stage 17/18 promotes an increase in the
affect later-born retinal cell types. Mash1, a mammalianrepresentation of retinal ganglion cells, the earliest born cell type.
homolog of the Drosophila achaete-scute bHLH family,n  1225 cells from 12 embryos for GFP and n  822 cells from 10
regulates the formation of later-born bipolar neuronsembryos for Xath5.
(B) Lipofection of Xath5 later at stage 26 promotes an increase in (Hatakeyama et al., 2001; Tomita et al., 1996). Expres-
the representation of bipolar cells and photoreceptor cells, which sion of Mash1 in Xenopus retinal progenitor cells biases
are later-born cell types. In both cases, the differentiation of Mu¨ller retinoblast differentiation toward a bipolar cell fate
glial cells was suppressed. n  381 cells from six embryos for GFP
(Brown et al., 1998; Figure 7). Both Mash1 and its Xeno-and n  335 cells from nine embryos for Xath5.
pus homolog, Xash1, contain GSK3 consensus phos-Error represents SEM; asterisks represent significant difference, as
phorylation sites (SPTISP), making them possible tar-compared to GFP controls; p 0.01 by Student’s t test. GC, ganglion
cells; HC, horizontal cells; AM, amacrine cells; BP, bipolar cells; PR, gets for regulation by GSK3. To test whether Mash1
photoreceptor cells; and MU, Mu¨ller glial cells. and Xash1 activities could be modulated by GSK3, we
used 16-cell RNA injection to target overexpression to
retinal progenitor cells using 10 pg dnGSK3mRNA and
10 pg Mash1 or Xash1 mRNA. As before, GFP mRNAThe Timing of Xath5 Expression Influences
Retinal Cell Type Specification was included as a tracer. While Mash1 mRNA alone
resulted in a bias toward bipolar cells (34%, p  0.001)If timing of bHLH function is an important determinant
of retinal cell fate, then forced expression of Xath5 later at the expense of ganglion cells and horizontal cells,
co-injection of Mash1 mRNA with dnGSK3 mRNA re-during retinogenesis should not bias toward ganglion
cells but, rather, promote the differentiation of later-born sulted in an increase in the representation of ganglion
cells relative to controls (Figure 7A). 49% of labeled cellscell types. Alternatively, if Xath5 expression dictates the
retinal ganglion cell fate, then one might expect that adopted ganglion cell fates at the expense of later-born
cell types. This 2.4-fold increase is similar to that ob-Xath5 would promote ganglion cell differentiation, re-
gardless of the timing of expression. To target Xath5 served in Xath5 or XNeuroD (S→A)-injected embryos. Simi-
larly, Xash1 injection alone resulted in an increase in theoverexpression to retinal progenitors at later stages of
retinogenesis, we used DNA lipofection to allow us to percentage of bipolar cells, as compared to controls
(39% increase, p  0.001), with decreases in ganglionmore precisely control the timing of expression (Holt
et al., 1990). In general, protein expression becomes cells (25% decrease, p  0.044) and photoreceptors
(24% decrease, p  0.003; Figure 7B). Co-injection withdetectable approximately 6–8 hr after transfection (Dor-
sky et al., 1997). Transfection of Xath5 DNA at stage 17/ dnGSK3 only slightly increased the representation of
ganglion cells (18% versus 14%, p  0.114). Instead,18 (neural fold stage) results in Xath5 overexpression
at early stages of retinal neurogenesis (approximately there appeared to be an increase in the percentage of
photoreceptors (35% increase, p  0.001). This ob-stage 25) and causes an increased proportion of gan-
glion cells, as compared to GFP controls (Figure 6A; p served increase in photoreceptors was due to the in-
crease in cones, another early-born cell type. The num-0.001, Kanekar et al., 1997). Lipofection of control GFP
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ber of photoreceptor cells staining for calbindin, which
marks cones in stage 41 retinas (Dorsky et al., 1997),
was increased by 38% in retinas from dnGSK3/Xash1-
injected embryos, as compared to the Xash1-injected
embryos (Figure 7C). This result indicates that release
from inhibition at early stages allows Xash1 to promote
early, rather than late, cell fates as well. Similar results
were obtained with Drosophila scute, which also pro-
motes bipolar differentiation when overexpressed in the
Xenopus retina, but early-born cell types when coex-
pressed with dnGSK3 (data not shown). Our results
demonstrate that the activities of additional bHLH fac-
tors can be altered by inhibition of GSK3 in the retina
and are consistent with endogenous GSK3, serving to
regulate the activity of multiple factors that control the
differentiation of later-born cell types. Furthermore,
these findings demonstrate that bHLH factors from spe-
cies other than Xenopus can be regulated by GSK3.
Xath5 and XNeuroD Are Independently
Regulated during Retinogenesis
We have shown that the late-acting factors XNeuroD,
Mash1, and Xash1 are sensitive to inhibition by GSK3
in retinal progenitors, while the early-acting factor Xath5
is not. However, the genesis of early-born neurons is
also a coordinated process that is subject to control by
negative regulatory pathways. For example, the neuro-
genic Delta/Notch pathway can regulate retinal ganglion
cell differentiation and may play a more general role in
regulating the determination of early retinal cell types
(Dorsky et al., 1997). In the Xenopus retina, coexpression
of activated Notch with Xath5 by 16-cell RNA injection
can inhibit the ability of Xath5 to promote retinal ganglion
cell differentiation (Schneider et al., 2001). In the neural
plate, Notch is unable to inhibit XNeuroD function, al-
though this has not been addressed in the retina (Chitnis
and Kintner, 1996). This raises the possibility that during
retinal neurogenesis there is independent regulation of
the function of Xath5 and XNeuroD, which would allow
for precise coordination of retinal histogenesis at both
early and late stages of development. However, it is
possible that Notch can inhibit XNeuroD, but that the
inhibitory effect of GSK3 is dominant, masking a Notch
effect. To test this, we co-injected mRNAs for either
Xath5, XNeuroD, or XNeuroD(S→A), along with XE, an
activated form of the X-Notch-1 receptor lacking the
extracellular domain (Coffman et al., 1993), into a dorsal
Figure 7. GSK3 Can Regulate the Activity of Mash1 and Xash1 in blastomere of 16-cell stage embryos and assayed for
the Xenopus Retina effects on the ratios of retinal cell types. Activated Notch
(A) Overexpression of Mash1 by 16-cell RNA injection promotes an alone caused increases in the numbers of undifferenti-
increase in bipolar cell differentiation, compared to GFP control ated cells within the retina (Figure 8A) and was able
injections. Coexpression of dnGSK3 with Mash1 caused an in- to inhibit the ability of Xath5 to promote ganglion cellcrease in retinal ganglion cell differentiation. n  3655 cells from
differentiation when coexpressed by 16-cell RNA injec-17 embryos for GFP, n  793 cells from 5 embryos for Mash1, and
tion (Schneider et al., 2001; data not shown). In contrast,n  410 cells from 5 embryos for Mash1  dnGSK3.
(B) Overexpression of Xash1 promotes an increase in bipolar cell
differentiation, compared to GFP control injections. Coexpression
of dnGSK3 with Xash1 caused an increase in the percentage of
labeled cells found in the photoreceptor layer. n  3655 cells from Error represents SEM; the asterisks represent significant difference
17 embryos for GFP, n  1436 cells from 6 embryos for Xash1, and as compared to GFP controls, while the number signs represent
n  968 cells from 5 embryos for Xash1  dnGSK3. significant difference between coexpression of dnGSK3with either
(C) Coexpression of dnGSK3 with Xash1 caused an increase in the Mash1 or Xash1, as compared to injection of Mash1 or Xash1 alone;
number of GFP-labeled, calbindin-positive cone photoreceptors per p 0.01 by Student’s t test. GC, ganglion cells; HC, horizontal cells;
retina. n  5 embryos for Xash1 and n  5 embryos for Xash1  AM, amacrine cells; BP, bipolar cells; PR, photoreceptor cells; and
dnGSK3. MU, Mu¨ller glial cells.
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activated Notch did not suppress the ability of XNeuroD
or XNeuroD(S→A) to promote the differentiation of later-
born cell types or ganglion cells, respectively (Figures 8B
and 8C). These results indicate that Notch differentially
regulates Xath5 and XNeuroD in the retina, as well as
in the neural plate. The independent regulation of Xath5
and XNeuroD during retinal neurogenesis would allow
for precise temporal control over their function and,
thus, control over the cell types they produce throughout
retinal neurogenesis.
Interestingly, Ohnuma et al. (2002) have shown that
when Xath5 or XNeuroD is coexpressed by in vivo lipo-
fection with either activated Notch or other factors that
promote cell cycle arrest (such as p27Xic1), these factors
synergize to promote cell cycle exit and early differentia-
tion of retinal progenitors, giving rise to increases in
retinal ganglion cells. Thus, depending upon either the
timing of expression or relative levels of expression,
Notch may, in some cases, enhance rather than antago-
nize the differentiation activity of proneural bHLH
factors.
Discussion
Neuronal Phenotype and the Timing
of Neuronal Differentiation
It has been proposed that the competence of retinal
progenitors to generate different retinal cell types
changes over time, so that at any given time a progenitor
is competent to make only one or a few cell types (Cepko
et al., 1996; Livesey and Cepko, 2001). How do bHLH
factors contribute to cell fate decisions in the developing
retina? Our experiments support a model in which bHLH
factors can regulate retinal neuron differentiation, but
the neuronal subtype that results depends upon the
competence of the progenitor cell in which the bHLH
factor functions. Temporal control over bHLH factor ac-
tivity could be achieved in several ways. Transcriptional
regulation can determine when and where a gene is
expressed. For example, in the mouse retina, Math5 is
expressed early and is required for the differentiation of
retinal ganglion cells, while NeuroD is expressed later
and is required for the development of amacrine cells
(Brown et al., 1998; 2001; Cai et al., 2000; Wang et al.,
Figure 8. Activated Notch Does Not Inhibit the Function of XNeuroD 2001). It is also possible that at a given stage of develop-
or XNeuroD(S→A) in Retinal Progenitor Cells ment, there is heterogeneity of bHLH expression within
(A) Overexpression of XE, an activated form of the Notch receptor progenitors, so that not all progenitors differentiate atlacking the extracellular domain, by 16-cell RNA injection sup-
the same time or adopt the same fate. For example, inpresses retinal neuron differentiation and causes an increase in
the rodent retina, Mash1 is expressed later in retinogen-undifferentiated neuroepithelial cells (NEP), as compared to GFP
controls. n  3655 cells from 17 embryos for GFP and n  1090 esis but only in a subset of proliferating progenitors
cells from 6 embryos for XE. (Jasoni and Reh, 1996). Nieto et al. (2001) have also
(B) Overexpression of XNeuroD alone promotes amacrine cell (AM) found that cerebral cortical progenitors are heteroge-
differentiation, and this ability is not inhibited by coexpression of neous with respect to ngn2 expression. Here, we showXE. n  3655 cells from 17 embryos for GFP, n  2886 cells from
that differential activity of bHLH factors is possible even21 embryos for XNeuroD, and n  3281 cells from 9 embryos for
for factors that are coexpressed, since posttranslationalXNeuroD  XE.
(C) Similarly, coexpression of XE with XNeuroD(S→A) does not inhibit mechanisms can regulate the timing of bHLH factor
its ability to promote retinal ganglion cell (GC) differentiation. n  function.
3655 cells from 17 embryos for GFP, n 3141 cells from 15 embryos The effects of timing of bHLH expression and/or func-
for XNeuroD(S→A), and n 605 cells from 5 embryos for XNeuroD(S→A) tion are not limited to the Xenopus retina. Overexpres-XE.
sion of NeuroD in rat retinas has different effects onError represents SEM; asterisks represent significant difference as
retinal neuron differentiation that is, to some extent,compared to GFP controls; p 0.01 by Student’s t test. GC, ganglion
cells; HC, horizontal cells; AM, amacrine cells; BP, bipolar cells; PR, dependent upon time of expression (Morrow et al.,
photoreceptor cells; and MU, Mu¨ller glial cells. 1999). Infection of a retrovirus expressing NeuroD in
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murine retinas in vivo at postnatal day (P)0 or P4 during mitter phenotypes, may be differentially controlled by
distinct bHLH factors or combinations of factors (Mat-the peak of amacrine cell genesis increased the number
of amacrine cells, while infection at P7 had no effect on ter-Sadzinski et al., 2001).
How do retinal bHLH factors regulate the developmentamacrine cells (Morrow et al., 1999). The effect on rod
photoreceptor differentiation was different, with no in- of specific subtypes of neurons during normal develop-
ment? We favor the hypothesis that acquisition of thecrease in rod photoreceptors following infection at P0
and modest increases observed with infection at P4 final retinal phenotype requires unique combinations of
transcription factors and their downstream targets. Inand P7 (Morrow et al., 1999). The effects of NeuroD
overexpression at earlier stages of retinal development support of this, it has been shown that acquisition of
bipolar cell identity requires the activity of both bHLHwere not tested. It is reasonable to postulate that mole-
cules that either interact with NeuroD or are required in factors (such as Mash1 or Math3) and the homeobox
factor Chx10 (Hatakeyama et al., 2001). Similarly, duringcombination with NeuroD also change in expression
and/or activity levels over time, resulting in a different spinal cord development in chick, expression of Ngn1
is insufficient to specify the motor neuron fate unlessprofile of retinal cell types. These experiments, together
with our findings, suggest that in the developing verte- coexpressed with olig2 (Mizuguchi et al., 2001; Novitch
et al., 2001). Thus, in the case of retinal ganglion cellbrate retina, the timing of bHLH factor function is impor-
tant for determining what neuronal cell type is gen- differentiation, bHLH factors (such as Xath5 and XNeu-
roD) may be able to couple to a retinal ganglion cell-erated.
specific program of differentiation, such as activation
of XBrn3d expression (Hutcheson and Vetter, 2001), butbHLH Factors and the Neuronal Subtype Decision
whether this actually occurs during development mayIn the developing Xenopus retina, we have found that
depend upon the complement of other factors ex-a GSK3-insensitive form of XNeuroD can specify the
pressed in the progenitor cells.same retinal cell type as Xath5, even though Xath5 nor-
mally promotes ganglion cells and XNeuroD does not.
Mechanism of GSK3 RegulationThere are other instances where bHLH factors have simi-
How is GSK3 regulating the function of bHLH factors,lar ability to regulate the development of specific neu-
such as XNeuroD? Since the integrity of the GSK3ronal subtypes. For example, the retinas in Mash1/
consensus phosphorylation site is critical for regulatingMath3 double knockouts completely lack bipolar cells,
the timing of XNeuroD and mNeuroD(I→V) function, it iswhile the single knockouts have relatively normal bipolar
likely that GSK3 is directly phosphorylating thesecells, indicating that either gene can complement the
proteins. However, purified GSK3 protein failed toloss of the other in the retina (Hatakeyama et al., 2001).
phosphorylate in vitro translated XNeuroD in an im-Furthermore, overexpression of bHLH factors, such as
mune-complex kinase assay (data not shown). This isMash1, Math3, NeuroD, and ngn2, in mouse retinal ex-
not surprising, since many substrates of GSK3 mustplants promotes the differentiation of rods, the predomi-
first be “primed” or phosphorylated by another kinasenant cell type being generated at the time of the experi-
at the most carboxy-terminal serine in the consensusment (Hatakeyama et al., 2001). Similarly, in the murine
phosphorylation sequence before the substrate will becerebral cortex, bHLH factors (such as Ngn1, Ngn2, and
recognized and phosphorylated by GSK3 (reviewed inMash1) can all induce the differentiation of neurons ap-
Frame and Cohen, 2001). It also remains a possibilitypropriate to the age of the animal when they are overex-
that XNeuroD is not a direct target for phosphorylationpressed, suggesting that layer-specific information is
by GSK3. Nevertheless, our data demonstrate thatnot provided by these bHLH factors (Cai et al., 2000).
GSK3plays a critical role in regulating XNeuroD activityHowever, differences between other bHLH factors
in vivo.have been observed, suggesting that not all bHLH fac-
GSK3 is generally active unless specifically inacti-tors have equivalent function. Murine knockout experi-
vated through various signaling pathways (reviewed inments suggest that some aspects of the neuronal phe-
Frame and Cohen, 2001). It is not yet known what turnsnotype, such as regional identity, may depend on the
GSK3 regulation off later in retinogenesis, so thatactivity of specific bHLH factors. In both ngn2 and ngn1/
XNeuroD and other GSK3-sensitive bHLH factors canngn2 knockout animals, the compensatory upregulation
be active to promote differentiation. Candidates includeof Mash1 expression in dorsal cortical progenitors re-
wnt/frizzled signaling (Wodarz and Nusse, 1998), GSK3sults in conversion of neurons in the dorsal telencepha-
binding protein (GBP; Yost et al., 1998), or receptor tyro-lon to those with ventral characteristics (Fode et al.,
sine kinase signaling. Further experiments will be neces-2000). In Drosophila, there is evidence for specificity in
sary to define which signaling pathways regulate GSK3the ability of different proneural bHLH factors to direct
activity during retinal neurogenesis.the development of different classes of neurons in the
peripheral nervous system (reviewed in Bray, 2000). In
addition, in Xenopus, overexpression of Xath3 promotes GSK3 Regulation of NeuroD in Other Vertebrates
The consensus sequence for GSK3 phosphorylation isthe formation of both ganglion cells and cone photore-
ceptors (Perron et al., 1999), while overexpression of conserved in the NeuroD sequences of Xenopus zebra-
fish and goldfish but is absent in NeuroD sequencesXath5 only promotes ganglion cell differentiation (Ka-
nekar et al., 1997), even after targeting expression to from mouse, chick, rat, and human (data not shown). In
fish and amphibians, retinogenesis takes place over astages when large numbers of both types of early cells
are being generated (data not shown). Furthermore, sub- short period of time: roughly 24 hr in Xenopus and 2–3
days in zebrafish (Holt et al., 1988; Hu and Easter, 1999),type-specific properties of neurons, such as neurotrans-
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roD(S→A) were in the pCS2MT vector. For the two-cell injections,as compared to 11 days in chick and over 2 weeks in
mRNAs were injected as previously described (Kanekar et al., 1997)mouse (reviewed in Altshuler et al., 1991). Thus, in chick
at the following amounts: 100 pg -Gal, 400 pg Xath5, 400 pg XNeu-and mouse, transcriptional regulation may ensure that
roD, 400 pg XNeuroD(S→A), and 2 ng GSK3 in a 4 nL volume. -GalbHLH factors involved in the development of distinct was used as a lineage tracer in the two-cell experiments. For all
cell types are, for the most part, expressed in sequential experiments, identical results were obtained when full-length, non-
myc-tagged XNeuroD in pCS2 (kind gift of Shin-ichi Ohnuma) wasand nonoverlapping patterns. For example, Math5,
used instead of pCS2MT XNeuroD. Embryos were allowed to de-which is important for ganglion cell synthesis, is ex-
velop in one-tenth full dilution MMR to neural plate stages accordingpressed earlier in retinal development than Mash1,
to Nieuwkoop and Faber (1994). The embryos were fixed in MEMFAwhich is important for bipolar cell differentiation (Brown
(Harland, 1991) for up to 1 hr, assayed for -galactosidase activity
et al., 1998). In contrast, in the Xenopus retina, expres- using previously described methods (Turner and Weintraub, 1994),
sion of multiple bHLH factors commences at the same and processed for whole-mount in situ hybridization, using a digoxi-
genin-labeled N-tubulin probe, as described in Kanekar et al. (1997).time and often even in the same cells (Kanekar et al.,
To determine effects on retinal cell fates, blastomeres at the 16-1997; Perron et al., 1998). Posttranslational regulation
or 32-cell stage were microinjected with 300 pg of GFP mRNA aswould allow progenitor cells to rapidly respond to envi-
a lineage tracer and 10 pg of each individual mRNA in a 1 nL volume.ronmental changes without de novo transcription/trans-
The injected blastomeres were either the major retinal progenitors
lation. (D1.1 or D1.2) or for calculating clone size, V1.2.1, a 32-cell stage
The presence of multiple regulatory pathways is likely blastomere (Huang and Moody, 1993).
critical for regulating the development of a full comple-
ment of retinal cell types in a short period of time and
In Vivo Lipofection of DNAmay allow the differentiation of different classes of neu-
DNA was transfected into the eye primorida of stage 17–18 or stage
rons to be regulated in response to extrinsic signals 26 embryos as previously described (Holt et al., 1990). pEGFP-C1
within the developing Xenopus retina. However, the fact plasmid DNA (Clontech) was cotransfected to mark the transfected
that bHLH factors from other species (including Mash1 cells.
and Drosophila scute) contained GSK3 consensus
phosphorylation sites and were sensitive to inhibition
Fixation and Retinal Cell Fate Analysisby GSK3 in our assay suggests that posttranslational
Embryos were raised in one-tenth full dilution MMR solution until
regulation of bHLH factor function may be important in stage 40/41 (Nieuwkoop and Faber, 1994). Embryos were fixed in
multiple species and in tissues other than the retina. In MEMFA, cryoprotected in sucrose phosphate buffer, embedded in
summary, we propose that posttranslational regulation OCT compound (Tissue Tek), and sectioned at 14 M on a cryostat.
Nuclear staining was performed by adding Hoescht dye to the washof bHLH function may be one mechanism that is used
solution at a final concentration of 0.0005%. GFP positive cells fromto generate diversity by modulating when a progenitor
central retina sections were identified and counted based on thewill undergo differentiation.
relative laminar position and morphology, as described in Dorsky
et al. (1995; 1997). In some cases, antibody staining was used to
Experimental Procedures confirm cell type. The results were compared using a 95% confi-
dence interval and the Student’s t test when the data were normally
Embryo Collection distributed and the Mann-Whitney U test, when the data did not fit
Xenopus laevis eggs were obtained by hormone-induced egg laying a normal distribution (SigmaStat 2.0, Jandel Scientific).
from adult frogs using standard methods. For 16- or 32-cell injec-
tions, only embryos exhibiting stereotypic cleavages (Moody, 1987)
were used to consistently identify retina-producing blastomeres Immunocytochemistry
across the population of experimental embryos (Huang and Moody, Primary antibodies were used at the following dilutions: Islet-1, 1:1,
1993). gift of Mahendra Rao, University of Utah; anti-Neurofilament, 1:1,
Chemicon; anti-calbindin, 1:100, Sigma; anti-GABA, 1:100, Diasorin;
Generation of XNeuroD(S→A) and mNeuroD(I→V) Constructs and anti-Pax6, 1:500 (Belecky-Adams et al., 1997; Mastick et al.,
To construct a GSK3-insensitive form of XNeuroD (pCS2 XNeu- 1997). An Alexa 568-conjugated donkey anti-mouse secondary anti-
roD[S→A]), amino acid residues 276 and 280 were changed from serine body was used at 1:300 (Molecular Probes, Inc., Eugene, OR). Nu-
to alanine. XNeuroD(S→A) was generated by overlap-extension PCR clear staining was performed by adding Hoescht dye to the wash
(Horton et al., 1989), using PFU polymerase (Gibco BRL, Gaithers- solution at a final concentration of 0.0005%. For identification of
burg, MD) and specific primers in conjunction with vector primers dopaminergic amacrine cells, embryos were raised until stage 44.
and pCS2 XNeuroD as a template. Primers: ND/GSKMUT-5 Anti-tyrosine hydroxylase staining was performed, as previously de-
CCACCCCTTGCTGTTAACGGGAACTTTAC and ND/GSKMUT-3 scribed (Huang and Moody, 1998).
AGCAAGGGGTGGGGCCAGGGGACCATCG. The PCR product was
cloned into the pCS2 vector using EcoRI and XbaI. A GSK3-
sensitive form of mNeuroD (mNeuroD[I→V]) was generated by chang- Acknowledgments
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